Transplantation Proceedings

Lung Transplantation for Cystic Fibrosis and Non-cystic Fibrosis Bronchiectasis: A Single-Center Experience.  51:2029-2034. 2019

Dosing Eculizumab for Antibody-Mediated Rejection in Kidney Transplantation: A Case Report.  48:3099-3105. 2016

Recurrent IgA Nephropathy After Kidney Transplantation.  48:2689-2694. 2016

Falsely incompatible b-cell flow cytometry crossmatch after pronase treatment: A case report.  47:831-833. 2015

Survey of First-Year Medical Students to Assess Their Knowledge and Attitudes Toward Organ Transplantation and Donation.  41:634-638. 2009

Can Machine Perfusion Decrease the Likelihood of Discard Among Biopsied Kidneys?.  40:1029-1031. 2008

A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients.  37:4303-4305. 2005

Preformed antibodies to α1,3-galactosyltransferase gene-knockout (GT-KO) pig cells in humans, baboons, and monkeys: Implications for xenotransplantation.  37:3514-3515. 2005

A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: The cincinnati experience.  37:802-803. 2005

Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression.  37:800-801. 2005

Chemotherapy for posttransplant lymphoproliferative disorder: The Israel Penn International Transplant Tumor Registry Experience.  37:956-957. 2005

Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy.  37:795-797. 2005

De novo colorectal cancer: Five-year survival is markedly lower in transplant recipients compared with the general population.  37:960-961. 2005

Donor kidneys with small renal cell cancers: Can they be transplanted?.  37:581-582. 2005

Early corticosteroid withdrawal under modern immunosuppression in renal transplantation: Multivariate analysis of risk factors for acute rejection.  37:798-799. 2005

Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis.  37:817-818. 2005

Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation.  37:812-813. 2005

Histocompatibility testing predicts acute rejection risk in early corticosteroid withdrawal regimens.  37:809-811. 2005

Laparoscopic living donor nephrectomy for kidneys with multiple arteries.  37:629-630. 2005

Laparoscopic right living donor nephrectomy.  37:631-632. 2005

Methicillin-resistant Staphylococcus aureus infection in liver transplantation: A matched controlled study.  37:1243-1244. 2005

Pilot study of early corticosteroid elimination after pancreas transplantation.  37:1287-1288. 2005

Posttransplant lymphoproliferative disorder: Significance of central nervous system involvement.  37:954-955. 2005

Potential of aspirin to inhibit thrombotic microangiopathy in α1,3-galactosyltransferase gene-knockout pig hearts after transplantation in baboons.  37:489-490. 2005

Prostate cancer prior to solid organ transplantation: The Israel Penn International Transplant Tumor Registry Experience.  37:958-959. 2005

Skin cancer following transplantation: The Israel Penn International Transplant Tumor Registry experience.  37:962-963. 2005

Limited engraftment capacity of bone marrow-derived mesenchymal cells in xenogeneic bone marrow transplantation.  35:504-505. 2003

Depletion of natural anti-pig antibodies by the continuous infusion of oligosaccharides in a pig-to-baboon model.  34:2757-2758. 2002

The role of mouse stroma in rat haematopoiesis in xenogeneic rat/mouse bone marrow transplantation chimeras.  34:2759. 2002

De novo breast cancer in renal transplant recipients.  34:1778-1779. 2002

De novo sarcomas in solid organ transplant recipients.  34:1786-1787. 2002

Delay of hepatitis C recurrence in liver transplant recipients: Impact of mycophenolate mofetil on transplant recipients with severe acute rejection or with renal dysfunction.  34:1561-1562. 2002

Gastric cancer in transplant recipients: Detection of malignacy by aggressive endoscopy.  34:1784-1785. 2002

Immunosuppression and merkel cell cancer.  34:1780-1781. 2002

Impact of noncompliance and donor/recipient race matching on chronic liver rejection.  34:1497-1498. 2002

Is there a need for surveillance endomyocardial biopsies in heart transplantation?.  34:1857-1859. 2002

Polyomavirus in kidney and kidney-pancreas transplantation: A defined protocol for immunosuppression reduction and histologic monitoring.  34:1788-1789. 2002

Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil.  34:1563-1564. 2002

Transplantation without steroids.  34:2076-2078. 2002

Biologic behavior of carcinoid tumors in solid organ transplant recipients: The Israel Penn international transplant tumor registry experience.  33:3656-3657. 2001

Kaposi sarcoma: An analysis of the US and international experiences from the Israel Penn international transplant tumor registry.  33:3660-3661. 2001

Effects of xenogeneic thymic transplantation in baboons.  33:766. 2001

Miniature swine and hDAF pig kidney transplantation in baboons treated with a nonmyeloablative regimen and CD154 blockade.  33:716. 2001

A nonmyeloablative regimen with CD40L blockade leads to humoral and cellular hyporesponsiveness to pig hematopoietic cells in baboons.  32:1100. 2000

Coagulation/thrombotic disorders associated with organ and cell xenotransplantation.  32:1099. 2000

Effect of B cell/plasma cell depletion or suppression on Anti-Gal antibody in the baboon.  32:1009. 2000

Experience with porcine thymic transplantation in baboons.  32:1048. 2000

Increases in autologous hematopoietic progenitors in the blood of baboons following irradiation and treatment with porcine stem cell factor and interleukin-3.  32:1045-1046. 2000

Induction of mixed hematopoietic chimerism in the pig-to-baboon model.  32:1101. 2000

Injection of porcine anti-idiotypic antibodies to primate anti-Gal antibodies leads to active inhibition of serum cytotoxicity in a baboon.  32:1102. 2000

Plasma perfusion by apheresis through a Gal immunoaffinity column successfully depletes anti-Gal antibody: Experience with 275 aphereses in baboons.  32:860. 2000

Von willebrand factor concentration, multimeric patterns, and cleaving protease activity in baboons undergoing xenogeneic peripheral blood stem cell transplantation.  32:990. 2000

Xenogeneic and allogeneic skin grafting after retrovirus-mediated SLA Class II DR gene transfer in baboons.  32:289-290. 2000

Erratum: Potential utility of rapamycin and tacrolimus in long-term, low-toxicity regimens (Transplantation Proceedings Vol. 31 (Suppl. 8A) (1999) (17S-22S)).  32:503-504. 2000

Construction of a recombinant adenovirus vector encoding Fas ligand with a CRE/Loxp inducible system.  31:792-793. 1999

Physiologic changes following brain death.  31:1001-1002. 1999

Potential utility of rapamycin and tacrolimus in long-term, low-toxicity regimens.  31:17-22. 1999

Xenogeneic thymic transplantation in a pig-to-nonhuman primate model.  31:957. 1999

The safety of xenotransplantation.  30:2461-2462. 1998

Race is not a critical factor in orthotopic liver transplantation..  29:3729-3730. 1997

Recurrent or persistent cardiac allograft rejection: therapeutic options and recommendations..  29:40S-44S. 1997

Renal transplantation in African-American recipients: three decades at a single center..  29:3726-3728. 1997

Molecular screening of xenodonor genomes for species-specific endogenous retroviral DNA sequences.  29:897-898. 1997

Recurrent or persistent cardiac allograft rejection: Therapeutic options and recommendations.  29:40S-44S. 1997

Molecular conjugate-mediated gene transfer in renal transplantation.  28:2046-2048. 1996

Class I and class II antigens in the rejection of murine islet cell transplants.  27:3234-3235. 1995

Functional effects of transplanted human fetal ventral mesencephalic brain tissue from spontaneous abortions into a rodent model of Parkinson's disease.  26:3335. 1994

RS-61443: A new immunosuppressive agent.  26:3144-3146. 1994

Effects of total parenteral nutrition on intestinal morphology and function in humans.  26:1457. 1994

Is xenotransplantation a realistic clinical option?.  24:2393-2396. 1992

Recent advances in the identification of significant human cytomegalovirus-encoded proteins..  23:64-69. 1991

Are black living-related renal donors at greater long-term risk of renal complications than white donors?.  23:1328-1329. 1991

Comparison of simple hypothermic storage, pulsatile perfusion with Belzer's gluconate-albumin solution, and pulsatile perfusion with UW solution for renal allograft preservation.  23:2394-2395. 1991

Limitation of free radical injury by reduced glutathione: An effective means of improving the recovery of heart transplants.  23:2440-2442. 1991

Accelerated cardiac allograft rejection associated with administration of liver cell extract in the baboon.  22:1966-1969. 1990

Age: A major determinant of renal dysfunction.  22:365-367. 1990

Effect of pharmacologic immunosuppression on donor heart survival in a closely related nonhuman primate xenograft model.  22:1086-1087. 1990

Pulsatile perfusion preservation: Early posttransplant dialysis requirement predicts rapid graft loss.  22:446-447. 1990

The exocrine secretions of the grafted pancreas.  21:3449-3451. 1989

Can cardiac allografts and xenografts be transplanted across the ABO blood group barrier?.  21:549-550. 1989

Can cardiac allografts and xenografts be transplanted across the ABO blood group barrier?.  21:549-550. 1989

Diagnosis of acute cardiac rejection by changes in left ventricular volumes..  21:2533. 1989

A parametric analysis of the hazard of cancer after transplantation.  21:3201-3204. 1989

Diagnosis of acute cardiac rejection by changes in left ventricular volumes.  21:2533. 1989

Early extranuclear effect of triiodothyronine (T3) on tissue slices: Relevance to organ donor viability.  21:1263-1264. 1989

Early graft function in primary and regraft recipients of paired cadaveric kidneys.  21:1274-1275. 1989

Electrocardiographic and histopathologic changes developing during experimental brain death in the baboon.  21:2567-2569. 1989

Lymphocytic IgM antibody in highly sensitized (>50% PRA) autologous negative renal allograft candidates.  21:739-741. 1989

Successful renal allografts in recipients with a positive standard, DTE negative cross-match.  21:746-747. 1989

Sustained high panel reactive antibody levels in highly sensitized patients: Significance of continued transfusions.  21:771-772. 1989

Use of cryopreserved donor bone marrow in cadaver kidney allograft recipients.  21:1787-1789. 1989

Added effects of organ (heart) storage after brain death in the experimental animal.  20:39-43. 1988

Effects of hormonal therapy on subsequent organ (kidney) storage in the experimental animal.  20:55-58. 1988

Endocrine changes and metabolic responses.  20:33-38. 1988

Hemodynamic and electrocardiographic responses.  20:25-28. 1988

Hormonal therapy in the brain-dead experimental animal.  20:51-54. 1988

Myocardial and pulmonary histopathologic changes.  20:29-32. 1988

Results of hormonal therapy in human brain-dead potential organ donors.  20:59-62. 1988

Induction of suppressor T cells by cytokines.  20:1156-1157. 1988

Added effects of organ (heart) storage after brain death in the experimental animal..  20:39-43. 1988

Effects of hormonal therapy on subsequent organ (kidney) storage in the experimental animal..  20:55-58. 1988

Endocrine changes and metabolic responses..  20:33-38. 1988

Hemodynamic and electrocardiographic responses..  20:25-28. 1988

Hormonal therapy in the brain-dead experimental animal..  20:51-54. 1988

Myocardial and pulmonary histopathologic changes..  20:29-32. 1988

Results of hormonal therapy in human brain-dead potential organ donors..  20:59-62. 1988

Cyclosporine impairs the renal response to volume depletion.  20:568-571. 1988

Cyclosporine neurotoxicity in liver transplant recipients: Report of three cases.  20:116-118. 1988

Early graft loss in cyclosporine A-treated cadaveric renal allograft recipients receiving retransplants against previous mismatched HLA-A, -B, -DR donor antigens.  20:170-172. 1988

Preservation by pulsatile perfusion improves early renal allograft function.  20:865-868. 1988

The physiological management of cardiac transplant donors and recipients using triiodothyronine.  20:803-805. 1988

Triiodothyronine therapy in the cardiac transplant recipient.  20:65-68. 1988

Brain death, triiodothyronine depletion, and inhibition of oxidative phosphorylation: Relevance to management of organ donors.  19:4110-4111. 1987

Is ABO compatibility essential in xenografting between closely related species?.  19:4437-4440. 1987

Prolongation of cardiac xenograft (vervet monkey to baboon) function by a combination of total lymphoid irradiation and immunosuppressive drug therapy.  19:4441-4442. 1987

Virological implications of the use of primates in xenotransplantation.  19:4068-4069. 1987

Cardiac allograft survival in ABO blood group incompatible baboons.  19:1036-1038. 1987

Cardiac transplantation using discordant xenografts in a nonhuman primate model.  19:1153-1154. 1987

Unusual functional and biochemical properties of DR molecules from the HLA-DR1, B14 haplotype.  19:851-857. 1987

Cardiac allograft survival in ABO blood group incompatible baboons..  19:1036-1038. 1987

Cardiac transplantation using discordant xenografts in a nonhuman primate model..  19:1153-1154. 1987

Quadruple immunosuppressive therapy in whole pancreas transplantation..  19:2297-2299. 1987

Quadruple therapy for cadaver renal transplantation..  19:1917-1919. 1987

Unusual functional and biochemical properties of DR molecules from the HLA-DR1, B14 haplotype..  19:851-857. 1987

A technique for transplantation of a large adult kidney into an infant.  19:2953-2955. 1987

Are there indications for heterotopic heart transplantation today?.  19:2512-2513. 1987

The value of hormonal therapy in improving organ viability in the transplant donor..  19:2037-2038. 1987

Brain death-induced hemodynamic changes resulting in cardiac and pulmonary injury in the baboon.  18:1190-1192. 1986

Cadaver donor renal transplantation in insulin-dependent diabetics using cyclosporine and antilymphoblast globulin.  18:1720-1723. 1986

Evidence of myocardial and renal functional recovery following hormonal treatment after brain death.  18:613-615. 1986

Hemodynamic changes, myocardial injury, and pulmonary edema induced by sympathetic activity during the development of brain death in the baboon.  18:609-612. 1986

Improved function of stored hearts following hormonal therapy after brain death in pigs.  18:1419-1421. 1986

Sequential antilymphocyte globulin cyclosporine therapy in cadaver renal transplantation.  18:16-18. 1986

Two haplotype mismatched live donor renal transplantation in diabetics.  18:1730-1732. 1986

Analysis of flow cytometry and cytotoxicity crossmatches in renal transplantation.  17:2480-2481. 1985

Effects of brain death and hypothermic perfusion storage on donor heart function: An experimental study.  17:231-232. 1985

HLA restriction patterns of trinitrophenyl-specific proliferative human T cell clones.  17:972-977. 1985

Prediction of acute cardiac rejection using radionuclide scanning to detect left ventricular volume changes.  17:218-220. 1985

Use of cell line K562 and autologous B lymphoblastoid cell lines to identify and remove autoantibodies from the serum of renal patients.  17:171-173. 1985

Heterotopic versus orthotopic heart transplantation.  16:886-892. 1984

Correlation of B-cell antibodies and clinical course in DRw-typed renal allograft recipients.  13:942-944. 1981

The quality of life after liver transplantation.  11:252-256. 1979

Outcome of renal transplantation in patients with primary cytomegalovirus infection.  11:1288-1290. 1979

Suppressor T cells in the regulation of immune responses to allogeneic tissues.  10:19-22. 1978

Early recognition of chronic humoral rejection in long-term follow-up of kidney recipients by a comprehensive renal radionuclide study..  9:43-47. 1977

Serologic detection of antigens controlled by the Ir region of the H-2 complex in the mouse..  5:1811-1813. 1973